A Phase III Randomized Trial Evaluating Alirocumab 300 Mg Every 4 Weeks as Monotherapy or Add-On to Statin: ODYSSEY CHOICE I

Atherosclerosis - Netherlands
doi 10.1016/j.atherosclerosis.2016.08.043
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Bevacizumab in Age-Related Macular Degeneration: A Randomized Controlled Trial on the Effect of On-Demand Therapy Every 4 or 8 Weeks

Acta Ophthalmologica
MedicineOphthalmology
2018English

A Phase III Randomized Controlled Trial of Tiotropium Add-On Therapy in Children With Severe Symptomatic Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Low Incidence of Pneumocystis Carinii Pneumonia in HIV Patients Receiving 300 Mg Pentamidine Aerosol Every 2 Weeks

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
1992English

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial†

Journal of Clinical Lipidology
Internal MedicineNutritionCardiologyEndocrinologyCardiovascular MedicineDieteticsMetabolismDiabetes
2019English

The ODYSSEY DM-DYSLIPIDEMIA Trial: Confirming the Benefits of Alirocumab in Diabetic Mixed Dyslipidemia

Annals of Translational Medicine
Medicine
2017English

Efficacy and Safety of Alirocumab in Patients With or Without Prior Coronary Revascularization: Pooled Analysis of Eight ODYSSEY Phase 3 Trials

Atherosclerosis
Cardiovascular MedicineCardiology
2018English

Yoga as an Add-On Treatment in the Management of Schizophrenia: A Randomized Controlled Trial

Annals of General Psychiatry
PsychiatryMental Health
2006English

ACTG 260: A Randomized, Phase I-Ii, Dose-Ranging Trial of the Anti-Human Immunodeficiency Virus Activity of Delavirdine Monotherapy

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1999English

A Phase III, Multicenter, Randomized, Double-Blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-Rosette (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial

Clinical Therapeutics
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy